Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Cancer Immunology Research|September 14, 2019
Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK CellsArash Nanbakhsh, Anupallavi Srinivasamani, Sandra Holzhauer, et al.
Research Square|May 20, 2021
SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopeniaWen Zhu, Yongwei Zheng, Mei Yu, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Alternative splicing modulates chromatin interactome and phase separation of the RIF1 C-terminal domainAdenine Si-Hui Koo, Weiyan Jia, Sang Hwa Kim, et al.
Chest|April 22, 2017
IVIg for Treatment of Severe Refractory Heparin-Induced ThrombocytopeniaAnand Padmanabhan, Curtis G Jones, Shannon M Pechauer, et al.
Blood|September 18, 2008
Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5Ryan D Schulteis, Haiyan Chu, Xuezhi Dai, et al.
Leukemia|February 26, 2020
Mesenchymal stem cells suppress leukemia via macrophage-mediated functional restoration of bone marrow microenvironmentChengxiang Xia, Tongjie Wang, Hui Cheng, et al.
Research and Practice in Thrombosis and Haemostasis|September 8, 2023
Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19Ziyu Zhang, Wen Dai, Wen Zhu, et al.
Nature Immunology|June 20, 2018
Publisher Correction: Transcription factor Hoxb5 reprograms B cells into functional T lymphocytesMengyun Zhang, Yong Dong, Fangxiao Hu, et al.
Nature Immunology|February 14, 2018
Transcription factor Hoxb5 reprograms B cells into functional T lymphocytesMengyun Zhang, Yong Dong, Fangxiao Hu, et al.
Blood|November 22, 2024
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19Wen Zhu, Yongwei Zheng, Mei Yu, et al.
Pageof 12